The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

A screenwriter for Back to the Future issued a savage response after being questioned on a possible fourth sequel. The sci-fi ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

The writer of Back To The Future, Bob Gale, has given a blunt reaction to the idea of there ever being a fourth film.

Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Taryn Robertson, a professor at Randolph College, is currently fundraising and training to run a marathon for her father who ...

Shrinking star and music supervisor Christa Miller revealed that Shrinking Season 3 will start production next week in ...

"Back to the Future" screenwriter Bob Gale joined two of its stars, Lea Thompson and Christopher Lloyd, at the Saturn Awards ...

Michael J. Fox might have a wholesome reputation these days, but he and a bunch of his celebrity friends once got busted by ...